Laura Pozzi
Laura Pozzi has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Christian Lunetta
Centro Clinico NEMO, Fondazione Serena Onlus, Milano, Italy
3 shared publications- Federica Agosta
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute , Milan 20132
3 shared publications - Nilo Riva
3rd Neurology Unit and Motor Neuron Disease Centre Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
3 shared publications - Paola Carrera
Division of Genetics and Cell Biology, Unit of Genomics for Human Disease Diagnosis, San Raffaele Scientific Institute, Milan, Italy
3 shared publications - Yuri Matteo Falzone
Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications - Alessandro Romano
IRCCS San Raffaele Scientific Institute, Neuropathology Unit, Institute of Experimental Neurology and Division of Neuroscience, 20132 Milan, Italy
2 shared publications
Latest Publications
- Open Access
- 15 May 2023
- Published by Copernicus GmbH
A Roadmap to Strengthen Geoscience Education for Sustainable Development in Kenya
Meeting the targets of the 17 United Nations (UN) Sustainable Development Goals (SDGs) requires contributions from geoscientists. Like most countries, Kenya is faced with the triple dimensional challenge of balancing economic, social and environmental sustainability. Through implementation of its ‘Vision 2030’ strategy, Kenya aims to transform into a high-functioning, industrialised middle-income country, providing a high quality of life to all its citizens by 2030. The country’s constitution harmonises with Vision 2030 and entitles every Kenyan to a clean and secure environment. This background provides an integrated roadmap entrenched in the SDGs. Kenya has also committed to implementing the African Union Agenda 2063 and the East African Community (EAC) Vision 2050, both aiming to build a more prosperous Africa. Eradicating extreme poverty, waste management, disaster preparedness, ensuring affordable, clean and sustainable energy, improving access to clean water, promoting sustainable consumption and production, environmental sustainability, building resilience to climate change impacts and managing Kenya's natural resources are some of the key elements of these policies. Here, we highlight the importance of geoscience education in accelerating the critical goals of Kenya’s Vision 2030 and the SDGs. We synthesise key policy documents to explore sustainable development priorities at the national and county level in the context of geoscience in Kenya and explore the relevant geoscience training and skills needed to help address these priorities. We demonstrate that geoscience will continue to be instrumental for achievement of the SDGs and overall performance on socio-economic development in Kenya. Baseline assessments of the geoscience courses available, including training and description of modules offered in Kenya's higher institutions, were compiled and analysed. The extent of the existing geoscience workforce and future workforce required to deliver on Kenya's Vision 2030 and the SDGs was identified through online surveys, focus group discussions, and interviews. We mapped the future needs against the training available and existing current workforce capacity to conduct a skills gap analysis. We identify a number of needs, including (1) to embed sustainability concepts into geoscience curriculum; (2) to expand provision of specialist postgraduate courses (e.g. MSc); (3) to strengthen access to field-based training in both undergraduate and postgraduate degrees; (4) to increase the number of trained geoscientists; (5) improved communication between geoscientists and policymakers. We conclude with a roadmap to address these gaps, embedding good practice from the UN Technology Facilitation Mechanism, and include transferable insights for other national settings.
- 15 May 2023
- Published by Copernicus GmbH
Open AccessA Roadmap to Strengthen Geoscience Education for Sustainable Development in Kenya
Meeting the targets of the 17 United Nations (UN) Sustainable Development Goals (SDGs) requires contributions from geoscientists. Like most countries, Kenya is faced with the triple dimensional challenge of balancing economic, social and environmental sustainability. Through implementation of its ‘Vision 2030’ strategy, Kenya aims to transform into a high-functioning, industrialised middle-income country, providing a high quality of life to all its citizens by 2030. The country’s constitution harmonises with Vision 2030 and entitles every Kenyan to a clean and secure environment. This background provides an integrated roadmap entrenched in the SDGs. Kenya has also committed to implementing the African Union Agenda 2063 and the East African Community (EAC) Vision 2050, both aiming to build a more prosperous Africa. Eradicating extreme poverty, waste management, disaster preparedness, ensuring affordable, clean and sustainable energy, improving access to clean water, promoting sustainable consumption and production, environmental sustainability, building resilience to climate change impacts and managing Kenya's natural resources are some of the key elements of these policies. Here, we highlight the importance of geoscience education in accelerating the critical goals of Kenya’s Vision 2030 and the SDGs. We synthesise key policy documents to explore sustainable development priorities at the national and county level in the context of geoscience in Kenya and explore the relevant geoscience training and skills needed to help address these priorities. We demonstrate that geoscience will continue to be instrumental for achievement of the SDGs and overall performance on socio-economic development in Kenya. Baseline assessments of the geoscience courses available, including training and description of modules offered in Kenya's higher institutions, were compiled and analysed. The extent of the existing geoscience workforce and future workforce required to deliver on Kenya's Vision 2030 and the SDGs was identified through online surveys, focus group discussions, and interviews. We mapped the future needs against the training available and existing current workforce capacity to conduct a skills gap analysis. We identify a number of needs, including (1) to embed sustainability concepts into geoscience curriculum; (2) to expand provision of specialist postgraduate courses (e.g. MSc); (3) to strengthen access to field-based training in both undergraduate and postgraduate degrees; (4) to increase the number of trained geoscientists; (5) improved communication between geoscientists and policymakers. We conclude with a roadmap to address these gaps, embedding good practice from the UN Technology Facilitation Mechanism, and include transferable insights for other national settings.
- Open Access
- 8 May 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (9) , 3346
Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort
Although the genetic architecture of amyotrophic lateral sclerosis (ALS) is incompletely understood, recent findings suggest a complex model of inheritance in ALS, which is consistent with a multistep pathogenetic process. Therefore, the aim of our work is to further explore the architecture of ALS using targeted next generation sequencing (NGS) analysis, enriched in motor neuron diseases (MND)-associated genes which are also implicated in axonal hereditary motor neuropathy (HMN), in order to investigate if disease expression, including the progression rate, could be influenced by the combination of multiple rare gene variants. We analyzed 29 genes in an Italian cohort of 83 patients with both familial and sporadic ALS. Overall, we detected 43 rare variants in 17 different genes and found that 43.4% of the ALS patients harbored a variant in at least one of the investigated genes. Of note, 27.9% of the variants were identified in other MND- and HMN-associated genes. Moreover, multiple gene variants were identified in 17% of the patients. The burden of rare variants is associated with reduced survival and with the time to reach King stage 4, i.e., the time to reach the need for percutaneous endoscopic gastrostomy (PEG) positioning or non-invasive mechanical ventilation (NIMV) initiation, independently of known negative prognostic factors. Our data contribute to a better understanding of the molecular basis of ALS supporting the hypothesis that rare variant burden could play a role in the multistep model of disease and could exert a negative prognostic effect. Moreover, we further extend the genetic landscape of ALS to other MND-associated genes traditionally implicated in degenerative diseases of peripheral axons, such as HMN and CMT2.
- 8 May 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (9) , 3346
Open AccessBurden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort
Although the genetic architecture of amyotrophic lateral sclerosis (ALS) is incompletely understood, recent findings suggest a complex model of inheritance in ALS, which is consistent with a multistep pathogenetic process. Therefore, the aim of our work is to further explore the architecture of ALS using targeted next generation sequencing (NGS) analysis, enriched in motor neuron diseases (MND)-associated genes which are also implicated in axonal hereditary motor neuropathy (HMN), in order to investigate if disease expression, including the progression rate, could be influenced by the combination of multiple rare gene variants. We analyzed 29 genes in an Italian cohort of 83 patients with both familial and sporadic ALS. Overall, we detected 43 rare variants in 17 different genes and found that 43.4% of the ALS patients harbored a variant in at least one of the investigated genes. Of note, 27.9% of the variants were identified in other MND- and HMN-associated genes. Moreover, multiple gene variants were identified in 17% of the patients. The burden of rare variants is associated with reduced survival and with the time to reach King stage 4, i.e., the time to reach the need for percutaneous endoscopic gastrostomy (PEG) positioning or non-invasive mechanical ventilation (NIMV) initiation, independently of known negative prognostic factors. Our data contribute to a better understanding of the molecular basis of ALS supporting the hypothesis that rare variant burden could play a role in the multistep model of disease and could exert a negative prognostic effect. Moreover, we further extend the genetic landscape of ALS to other MND-associated genes traditionally implicated in degenerative diseases of peripheral axons, such as HMN and CMT2.
- 1 December 2019
- Published by Elsevier in Neurobiology of Aging
- Vol. 84, 239.e9-239.e14
Coexistence of variants in TBK1 and in other ALS-related genes elucidates an oligogenic model of pathogenesis in sporadic ALS
- 1 December 2019
- Published by Elsevier in Neurobiology of Aging
- Vol. 84, 239.e9-239.e14
Coexistence of variants in TBK1 and in other ALS-related genes elucidates an oligogenic model of pathogenesis in sporadic ALS
- 22 April 2019
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 20 (5-6) , 449-452
Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72
We describe a patient, previously known for NMOSD, who presented a rapidly progressive worsening of muscle strength, respiratory, and bulbar functions. ALS associated with cognitive impairment was diagnosed, while genetic analysis revealed a hexanucleotide repeat expansion in the C9orf72 gene. To the best of our knowledge, this is the first reported C9orf72-ALS patient with concurrent NMOSD. In consideration of the low prevalence of these two diseases, a by-chance co-occurrence is unlikely. Although the discovery of a disease-specific serum AQP4-IgG antibody has led to a broadening of the NMOSD, a progressive neurological deterioration, as shown by our patient, should be considered as a “red flag”, leading to alternative diagnostic hypotheses. Our report supports the hypothesis that in C9orf72-ALS neuroinflammation may contribute to disease penetrance or to determine an aggressive clinical phenotype. Further investigations are needed in order to establish possible shared neuroinflammatory patterns between ALS, NMOSD, and other neuroinflammatory disorders.
- 22 April 2019
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 20 (5-6) , 449-452
Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72
We describe a patient, previously known for NMOSD, who presented a rapidly progressive worsening of muscle strength, respiratory, and bulbar functions. ALS associated with cognitive impairment was diagnosed, while genetic analysis revealed a hexanucleotide repeat expansion in the C9orf72 gene. To the best of our knowledge, this is the first reported C9orf72-ALS patient with concurrent NMOSD. In consideration of the low prevalence of these two diseases, a by-chance co-occurrence is unlikely. Although the discovery of a disease-specific serum AQP4-IgG antibody has led to a broadening of the NMOSD, a progressive neurological deterioration, as shown by our patient, should be considered as a “red flag”, leading to alternative diagnostic hypotheses. Our report supports the hypothesis that in C9orf72-ALS neuroinflammation may contribute to disease penetrance or to determine an aggressive clinical phenotype. Further investigations are needed in order to establish possible shared neuroinflammatory patterns between ALS, NMOSD, and other neuroinflammatory disorders.
- 1 February 2019
- Published by Elsevier in The Lancet Neurology
- Vol. 18 (2) , 155-164
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
- 1 February 2019
- Published by Elsevier in The Lancet Neurology
- Vol. 18 (2) , 155-164
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
- Open Access
- 19 August 2017
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 88 (10) , 869-875
TBK1mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation
Background TANK-binding kinase 1 (TBK1) gene has been recently identified as a causative gene of amyotrophic lateral sclerosis (ALS). Methods We sequenced the TBK1 gene in a cohort of 154 Italian patients with ALS with unclear genetic aetiology. We subsequently assessed the pathogenic potential of novel identified TBK1 variants using functional in vitro studies: expression, targeting and activity were evaluated in patient-derived fibroblasts and in cells transfected with mutated-TBK1 plasmids. Results We identified novel genomic TBK1 variants including two loss-of-function (LoF) (p.Leu59Phefs*16 and c.358+5G>A), two missense (p.Asp118Asn and p.Ile397Thr) and one intronic variant (c.1644–5_1644-2delAATA), in addition to two previously reported pathogenetic missense variants (p.Lys291Glu and p.Arg357Gln). Functional studies in patient-derived fibroblasts revealed that the c.358+5G>A causes aberrant pre-mRNA processing leading TBK1 haploinsufficiency. Biochemical studies in cellular models showed that the truncating variant p.Leu59Phefs*16 abolishes TBK1 protein expression, whereas the p.Asp118Asn variant severely impairs TBK1 phosphorylation activity. Conversely, the p.Ile397Thr variant displayed enhanced phosphorylation activity, whose biological relevance is not clear. Conclusion The observed frequency of TBK1 LoF variants was 1.3% (2/154), increasing up to 3.2% (5/154) by taking into account also the functional missense variants that we were able to classify as potentially pathogenic, supporting the relevance of TBK1 in the Italian population with ALS.
- 19 August 2017
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 88 (10) , 869-875
Open AccessTBK1mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation
Background TANK-binding kinase 1 (TBK1) gene has been recently identified as a causative gene of amyotrophic lateral sclerosis (ALS). Methods We sequenced the TBK1 gene in a cohort of 154 Italian patients with ALS with unclear genetic aetiology. We subsequently assessed the pathogenic potential of novel identified TBK1 variants using functional in vitro studies: expression, targeting and activity were evaluated in patient-derived fibroblasts and in cells transfected with mutated-TBK1 plasmids. Results We identified novel genomic TBK1 variants including two loss-of-function (LoF) (p.Leu59Phefs*16 and c.358+5G>A), two missense (p.Asp118Asn and p.Ile397Thr) and one intronic variant (c.1644–5_1644-2delAATA), in addition to two previously reported pathogenetic missense variants (p.Lys291Glu and p.Arg357Gln). Functional studies in patient-derived fibroblasts revealed that the c.358+5G>A causes aberrant pre-mRNA processing leading TBK1 haploinsufficiency. Biochemical studies in cellular models showed that the truncating variant p.Leu59Phefs*16 abolishes TBK1 protein expression, whereas the p.Asp118Asn variant severely impairs TBK1 phosphorylation activity. Conversely, the p.Ile397Thr variant displayed enhanced phosphorylation activity, whose biological relevance is not clear. Conclusion The observed frequency of TBK1 LoF variants was 1.3% (2/154), increasing up to 3.2% (5/154) by taking into account also the functional missense variants that we were able to classify as potentially pathogenic, supporting the relevance of TBK1 in the Italian population with ALS.
- Open Access
- 29 October 2013
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (4) , 874-885
Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation
Duchenne muscular dystrophy (DMD) is an hereditary disease characterized by loss of muscle fibers and their progressive substitution by fat and fibrous tissue. Mesenchymal fibro-adipogenic progenitors (FAPs) expressing the platelet-derived growth factor receptor alpha (PDGFRα) are an important source of fibrosis and adipogenesis in dystrophic skeletal muscle. Among the therapies suggested for dystrophy are those based on nitric oxide (NO) donating drugs, the administration of which slows disease progression. NO has been shown to act by enhancing the regenerative potential of the diseased muscle. Whether it acts also by inhibiting fibrosis and adipogenesis was not known. Here, we show in vitro that NO regulates FAP fate through inhibition of their differentiation into adipocytes. In mdx mice, an animal model of DMD, treatment with the NO donating drug molsidomine reduced the number of PDGFRα+ cells as well as the deposition of both skeletal muscle fat and connective tissues. Inhibition of adipogenesis was due to NO-induced increased expression of miR-27b leading to downregulation of peroxisome proliferator-activated receptors gamma (Pparγ1) expression in a pathway independent of cGMP generation. These findings reveal an additional effect of NO in dystrophic muscle that conceivably synergizes with its known effects on regeneration improvement and explain why NO-based therapies appear effective in the treatment of muscular dystrophy. Stem Cells 2014;32:874–885
- 29 October 2013
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (4) , 874-885
Open AccessNitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation
Duchenne muscular dystrophy (DMD) is an hereditary disease characterized by loss of muscle fibers and their progressive substitution by fat and fibrous tissue. Mesenchymal fibro-adipogenic progenitors (FAPs) expressing the platelet-derived growth factor receptor alpha (PDGFRα) are an important source of fibrosis and adipogenesis in dystrophic skeletal muscle. Among the therapies suggested for dystrophy are those based on nitric oxide (NO) donating drugs, the administration of which slows disease progression. NO has been shown to act by enhancing the regenerative potential of the diseased muscle. Whether it acts also by inhibiting fibrosis and adipogenesis was not known. Here, we show in vitro that NO regulates FAP fate through inhibition of their differentiation into adipocytes. In mdx mice, an animal model of DMD, treatment with the NO donating drug molsidomine reduced the number of PDGFRα+ cells as well as the deposition of both skeletal muscle fat and connective tissues. Inhibition of adipogenesis was due to NO-induced increased expression of miR-27b leading to downregulation of peroxisome proliferator-activated receptors gamma (Pparγ1) expression in a pathway independent of cGMP generation. These findings reveal an additional effect of NO in dystrophic muscle that conceivably synergizes with its known effects on regeneration improvement and explain why NO-based therapies appear effective in the treatment of muscular dystrophy. Stem Cells 2014;32:874–885
- 1 March 1991
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 175 (2) , 459-466
Transgenic mice mimic the methylation pattern of the human HLA-DRα gene
- 1 March 1991
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 175 (2) , 459-466
Transgenic mice mimic the methylation pattern of the human HLA-DRα gene